| Literature DB >> 35496124 |
Hongying Gao1, Reza Tayebee2, Mojtaba Fattahi Abdizadeh3,4, Esrafil Mansouri5, Maryam Latifnia6, Zahra Pourmojahed7.
Abstract
Vitex pseudo-negundo leaf extract (VPLE) is used to mediate the green biosynthesis of Ag and NiO nanoparticles in aqueous solutions under mild conditions. The synthesized nanoparticles, with a narrow size range and good distribution, are characterized by means of powder X-ray diffraction (PXRD), Fourier-transform infrared (FT-IR), scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDX), and transmission electron microscopy (TEM) techniques. SEM and TEM micrographs proved formation of mostly spherical or ellipsoidal nanoparticles with little agglomeration, and the average particle size was less than 20-35 nm for both types of nanoparticle. Then, the protective role of VPLE toward the liver is assessed in streptozotocin-induced diabetic rats. For this purpose, diabetes is induced in rats through the intraperitoneal injection of streptozotocin, and VPLE is administered via oral gavage for 6 weeks. This study suggests that VPLE can ameliorate biochemical and structural changes in the livers of diabetic rats, showing that VPLE can improve the condition of rats with diabetic hepatopathy via a decrease in oxidative stress and an enhancement in the activity of antioxidant enzymes in the liver. This journal is © The Royal Society of Chemistry.Entities:
Year: 2020 PMID: 35496124 PMCID: PMC9048759 DOI: 10.1039/c9ra08668d
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1The EDX patterns from (a) NiO and (b) Ag nanoparticles.
Fig. 2The PXRD patterns of (a) NiO and (b) Ag nanoparticles.
Fig. 3The FT-IR spectra of the synthesized (a) NiO and (b) Ag nanoparticles, and VPLE (c).
Fig. 4SEM images of (a) Ag and (b) NiO nanoparticles.
Fig. 5TEM images of (a) Ag and (b) NiO nanoparticles.
The effects of 6 weeks of VLHE administration (250 and 500 mg kg−1) on the fasting blood sugar and serum biomarker levels relating to the liver function of normal and streptozotocin-induced diabetic ratsa
| Parameter | Group | |||
|---|---|---|---|---|
| Healthy control | Diabetic control | VLHE (250 mg kg−1) | VLHE (500 mg kg−1) | |
| GLU (mg dl−1) | 94.4 ± 7.54 | 366.2 ± 139.26* | 148.5 ± 20.21** | 139 ± 28.91** |
| ALT (U/l) | 64.2 ± 11.0 | 145 ± 18.15* | 80.4 ± 5.94** | 72.6 ± 5.13** |
| AST (U/l) | 115.2 ± 10.91 | 205 ± 32.18* | 136.4 ± 11.97** | 119.8 ± 17.72** |
| ALP (U/l) | 112.8 ± 12.9 | 237 ± 58.83* | 140 ± 12.16** | 117.6 ± 7.7** |
| Alb (g dl−1) | 3.73 ± 0.26 | 2.19 ± 0.27* | 2.876 ± 0.24** | 3.062 ± 0.26** |
Results are expressed as mean ± SE (n = 5); * means in diabetic and healthy control groups are significantly different from each other (P < 0.01); ** means in diabetic + VLHE (250 and 500 mg kg−1) and diabetic groups are significantly different from each other (P < 0.05).
The effects of 6 weeks of VLHE administration (250 and 500 mg kg−1) on the antioxidant enzyme activities in the livers of normal and streptozotocin-induced diabetic ratsa
| Parameter | Group | |||
|---|---|---|---|---|
| Healthy control | Diabetic control | VLHE (250 mg kg−1) | VLHE (500 mg kg−1) | |
| GPx | 19.79 ± 0.60 | 10.44 ± 1.06* | 18.18 ± 1.02** | 18.24 ± 1.60** |
| SOD | 17.09 ± 0.78 | 11.80 ± 0.75* | 16.54 ± 0.47** | 16.93 ± 0.43** |
| MDA | 17.43 ± 1.09 | 30.18 ± 2.19* | 21.18 ± 1.29** | 20.10 ± 1.36** |
Results are expressed as mean ± SE (n = 5); * means in diabetic and healthy control groups are significantly different from each other (P < 0.01); ** means in diabetic + VLHE (250 and 500 mg kg−1) and diabetic groups are significantly different from each other (P < 0.05).
Fig. 6Histopathology examinations of liver tissue from different groups: (A) healthy control rat; (B) diabetic control rat; (C) VPLE-treated rat (250 mg kg−1 body weight); and (D) VPLE-treated rat (500 mg kg−1 body weight); H&E, 300×.